Blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...
A Promising New Biomarker Test Could Help Identify Alzheimer’s Risk Up To 10 Years Earlier
The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...
Which vehicles shined in new, tougher crash tests?
Nearly three-quarters of vehicles tested by IIHS' tougher front-crash prevention tests earned good or acceptable ratings.
HealthDay on MSN19h
Urine-Based Test Provides Accurate Testing Option for Advanced Prostate Cancer
The 18-gene MyProstateScore 2.0 (MPS2) test using first-catch non-digital rectal examination (DRE) urine is highly sensitive ...
Science News7h
A pancreatic cancer blood test called PAC-MANN could spot the disease early
The test relies on a magnetic nanoparticle linked to fluorescent molecules to detect pancreatic cancer proteins.
New immune-probing technique maps regulatory T cell interactions
Developing effective treatments and understanding how the mechanism of the immune system have always been challenging for ...
Healio11h
AI tool predicts response to, survival after treatment with immune checkpoint inhibitors
An AI tool appeared superior to two FDA-approved biomarkers for predicting how people with cancer will respond to immune ...
Aptose’s Frontline Triple Drug Therapy with Tuspetinib Achieves Notable Responses in Newly Diagnosed AML Patients in the Phase 1/2 TUSCANY Trial
In January 2025, Aptose announced the initiation of the TUSCANY trial and dosing in the first cohort of newly-diagnosed AML patients with the lowest starting dose (40 mg) of TUS as part of the ...